CAMBRIDGE, Mass., Dec. 2, 2020 /PRNewswire/ -- Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced that preclinical data from two pipeline programs that...
from PR Newswire: https://ift.tt/2KQWV6r
No comments:
Post a Comment